Total Trials has integrated Total Diversity Clinical Trial Management into its global organization, strengthening its position as a leading CRO. This strategic integration enhances US clinical trial capabilities, patient recruitment services, and global study delivery across multiple therapeutic areas.
Founded in 2013 and based in Texas, Total Diversity brings expertise in clinical trial management, patient recruitment, and retention services, supporting more efficient and patient-focused clinical research.
This integration expands Total Trials’ ability to support sponsors across key therapeutic areas including CNS disorders, dermatology, gastroenterology, ophthalmology, acute pain, and aging populations. It strengthens global CRO operations and improves the delivery of complex clinical studies.
The combined organization improves patient recruitment and retention capabilities, enabling faster enrollment and better access to diverse patient populations. This supports more efficient clinical trial execution and improved study outcomes for sponsors. All Total Diversity sponsors, projects, and ongoing clinical operations are being transitioned into the Total Trials portfolio, ensuring continuity of service while strengthening global execution and operational efficiency.
